CRISTINA DUBBERT: Open Payments
NPI 1730724873 · SYLVANIA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,410 in 102 payments from 13 companies in 2025. Trend: 2023 $1,811 · 2024 $2,126 · 2025 $2,410
Food & beverage: $2,410
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $853 |
| Ardelyx, Inc. | 9 | $362 |
| PFIZER INC. | 8 | $240 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $240 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $237 |
| Lilly USA, LLC | 6 | $107 |
| Aimmune Therapeutics, Inc. | 6 | $93 |
| Madrigal Pharmaceuticals | 4 | $82 |
| Ipsen Biopharmaceuticals, Inc | 4 | $81 |
| Phathom Pharmaceuticals, Inc. | 6 | $55 |
Products named: RINVOQ, IBSRELA, XIFAXAN, LINZESS, VELSIPITY, ENTYVIO, SKYRIZI, OMVOH.
Industry payments across OH — which companies pay providers there.
